Literature DB >> 7263914

Comparison of the inotropic and chronotropic effects of metoprolol and propranolol.

K A Conrad.   

Abstract

The cardiovascular responses to intravenous doses of isoproterenol were measured in eight male volunteers before and during administration of 50 mg metoprolol, orally every 6 hours and 40 mg propranolol, orally every 6 hours for a total of five doses. The dose of isoproterenol required to produce an increase in heart rate of 25 beats/min (the ID25) was 2.0 +/- 1.4 microgram before beta blockade, 6.2 +/- 4.4 microgram during metoprolol, and 44.4 +/- 12.0 microgram during propranolol administration. Similar changes in diastolic blood pressure, QS2I, preejection period, and preejection period/left ventricular ejection time ratio occurred at the ID25 during treatment with both metoprolol and propranolol. In volunteers, propranolol produces a much more intense blockade of the inotropic and chronotropic effects of isoproterenol than does metoprolol.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7263914     DOI: 10.1002/j.1552-4604.1981.tb02550.x

Source DB:  PubMed          Journal:  J Clin Pharmacol        ISSN: 0091-2700            Impact factor:   3.126


  4 in total

1.  Cardiovascular effects of theophylline. Partial attenuation by beta-blockade.

Authors:  K A Conrad; E H Prosnitz
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

2.  Disagreement between standard transthoracic impedance cardiography and the automated transthoracic electrical bioimpedance method in estimating the cardiovascular responses to phenylephrine and isoprenaline in healthy man.

Authors:  C De Mey; D Enterling
Journal:  Br J Clin Pharmacol       Date:  1993-04       Impact factor: 4.335

Review 3.  Metoprolol. An updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in hypertension, ischaemic heart disease and related cardiovascular disorders.

Authors:  P Benfield; S P Clissold; R N Brogden
Journal:  Drugs       Date:  1986-05       Impact factor: 9.546

Review 4.  Pharmacogenomics for Primary Care: An Overview.

Authors:  Victoria Rollinson; Richard Turner; Munir Pirmohamed
Journal:  Genes (Basel)       Date:  2020-11-12       Impact factor: 4.096

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.